Abstract:Background Gold nanoparticle toxicity research is currently leading towards the in vivo experiment. Most toxicology data show that the surface chemistry and physical dimensions of gold nanoparticles play an important role in toxicity. Here, we present the in vivo toxicity of 5, 10, 30, and 60 nm PEG-coated gold nanoparticles in mice. Methods Animal survival, weight, hematology, morphology, organ index, and biochemistry were characterized at a concentration of 4000 μg/kg over 28 days. Results The PEG-coated gold particles did not cause an obvious decrease in body weight or appreciable toxicity even after their breakdown in vivo. Biodistribution results show that 5 nm and 10 nm particles accumulated in the liver and that 30 nm particles accumulated in the spleen, while the 60 nm particles did not accumulate to an appreciable extent in either organ. Transmission electron microscopic observations showed that the 5, 10, 30, and 60 nm particles located in the blood and bone marrow cells, and that the 5 and 60 nm particles aggregated preferentially in the blood cells. The increase in spleen index and thymus index shows that the immune system can be affected by these small nanoparticles. The 10 nm gold particles induced an increase in white blood cells, while the 5 nm and 30 nm particles induced a decrease in white blood cells and red blood cells. The biochemistry results show that the 10 nm and 60 nm PEG-coated gold nanoparticles caused a significant increase in alanine transaminase and aspartate transaminase levels, indicating slight damage to the liver. Conclusion The toxicity of PEG-coated gold particles is complex, and it cannot be concluded that the smaller particles have greater toxicity. The toxicity of the 10 nm and 60 nm particles was obviously higher than that of the 5 nm and 30 nm particles. The metabolism of these particles and protection of the liver will be more important issues for medical applications of gold-based nanomaterials in future.

Biosafety risk assessment of gold and aluminum nanoparticles in tumor-bearing mice

Influence of Reducing Agents on Biosafety and Biocompatibility of Gold Nanoparticles

Synthesis, Characterization and Biosafety Evaluation of Hollow Gold Nanospheres.

Toxicologic Effects of Gold Nanoparticles in Vivo by Different Administration Routes

Investigating the fate and toxicity of green synthesized gold nanoparticles in albino mice

Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys

Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice

Bioavailability and Preliminary Toxicity Evaluations of Alumina Nanoparticles in Vivo after Oral Exposure

Cytotoxicity of Bsa-Stabilized Gold Nanoclusters: in Vitro and in Vivo Study

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

Neurotoxicity profiling of aluminum salt-based nanoparticles as adjuvants for therapeutic cancer vaccine

Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration.

Toxicity of Alumina Nanoparticles in the Immune System of Mice

Shape Dependence Of Gold Nanoparticles On In Vivo Acute Toxicological Effects And Biodistribution

Biocompatibility of Near-Ir Sensitive Au-Based Nanoparticles As the Potential Drug Delivery Carriers

Size-dependent in Vivo Toxicity of PEG-coated Gold Nanoparticles

The Systematic Evaluation of Size-Dependent Toxicity and Multi-Time Biodistribution of Gold Nanoparticles.

Pharmacokinetics, Clearance, and Biosafety of Polyethylene Glycol-Coated Hollow Gold Nanospheres

Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles

A higher aspect ratio enhanced bioaccumulation and altered immune responses due to intravenously-injected aluminum oxide nanoparticles

Exposure-time-dependent subcellular staging of gold nanoparticles deposition and vesicle destruction in mice livers